Serum level of vitamin D in obstructive sleep apnea patients with fibromyalgia syndrome

dc.contributor.authorDumur, Seyma
dc.contributor.authorYildirim, Tulay
dc.contributor.authorAlp, Recep
dc.contributor.authorKucur, Mine
dc.contributor.authorAydin, Murat
dc.date.accessioned2022-02-08T09:02:08Z
dc.date.available2022-02-08T09:02:08Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAbstract: Objectives: The aim of this study was to investigate the serum concentration of vitamin D in patients with obstructivesleep apnea syndrome (OSAS) alone and with coexisting fibromyalgia syndrome (FMS) and to assess the relationshipto pain.Methods: A total of 60 patients diagnosed with OSAS and 40 healthy individuals whose age and sex were analogousto the patient group were included in this study. The OSAS patients were examined for FMS according to the AmericanCollege of Rheumatology criteria, and 27 cases were identified. Group 1 consisted of patients with OSAS alone (n=33)and Group 2 comprised patients with FMS+OSAS (n=27). Serum samples were analyzed using an ultra-performanceliquid chromatography analyzer (Thermo Dionex Ultimate 3000; Thermo Fisher Scientific, Inc., Waltham, MA, USA).Results: A comparison of the OSAS and FMS+OSAS groups with the healthy individuals revealed that the vitamin Dlevel was significantly lower in the patient groups (Group 1: p=0.001, Group 2: p=0.038). No statistically significant difference was found in the vitamin D level between the subgroups of OSAS and FMS+OSAS. A weak negative correlationwas determined between the number of the tender points (r=-0.428) and the vitamin D level in the subjects with FMS(p=0.013). In addition, the oxygen desaturation values of the FMS+OSAS and OSAS patient groups were significantlydifferent (p=0.001).Conclusion: Patients with OSAS and FMS+OSAS had a low vitamin D level, which should be considered when planningtreatment strategiesen_US
dc.identifier.citationDUMUR S,YILDIRIM T,KUCUR M,ALP R,AYDIN M (2021). Serum level of vitamin D in obstructive sleep apnea patients with fibromyalgia syndrome. International Journal of Medical Biochemistry, 4(1), 36 - 41. Doi: 10.14744/ijmb.2020.44227en_US
dc.identifier.doi10.14744/ijmb.2020.44227en_US
dc.identifier.endpage41en_US
dc.identifier.issn2587-2362
dc.identifier.issn2618-642X
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85164313384en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage36en_US
dc.identifier.trdizinid417964en_US
dc.identifier.urihttps://doi.org/10.14744/ijmb.2020.44227
dc.identifier.urihttps://hdl.handle.net/11616/46833
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/417964
dc.identifier.volume4en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.relation.ispartofInternational Journal of Medical Biochemistryen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleSerum level of vitamin D in obstructive sleep apnea patients with fibromyalgia syndromeen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
8a9c7b40-67cc-417b-8784-c0fec103f3fe.pdf
Boyut:
211 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: